Fees in Respect of Drugs and Medical Devices Regulations (SOR/2011-79)

AMENDMENTS NOT IN FORCE

• — SOR/2019-134, s. 1

  • 1 The title of the Fees in Respect of Drugs and Medical Devices RegulationsFootnote ¹ is replaced by the following:

    • Return to footnote ¹SOR/2011-79

    Fees in Respect of Dealer’s Licences Regulations

• — SOR/2019-134, s. 2

  • 2 Section 1 of the Regulations and the headings before it are repealed.

• — SOR/2019-134, s. 3

  • 3 The heading before section 2 of the Regulations is repealed.

• — SOR/2019-134, s. 4

  • 4 Subsection 2(1) of the Regulations is replaced by the following:

    • Purpose — fees

      • 2 (1) The purpose of these Regulations is to prescribe the fees for the examination of an application for, or the renewal of, a dealer’s licence under Part G of the Food and Drug Regulations or under the Narcotic Control Regulations.

• — SOR/2019-134, s. 5

  • 5 Section 3 of the Regulations and the heading before it are repealed.

• — SOR/2019-134, s. 6

  • 6 The heading before section 4 of the Regulations is repealed.

• — SOR/2019-134, s. 7

  • 7 The headings before section 5 and sections 5 to 28 of the Regulations are repealed.

• — SOR/2019-134, s. 8

  • 8 The headings before section 29 of the Regulations are repealed.

• — SOR/2019-134, s. 9

  • • 9 (1) The portion of subsection 29(1) of the Regulations before the first definition is replaced by the following:

      • Definitions

        • 29 (1) The following definitions apply in sections 30, 31 and 33.

    • (2) Subsection 29(2) of the Regulations is replaced by the following:

      • Words and expressions

        (2) Unless the context otherwise requires, all other words and expressions used in sections 30, 31 and 33 have the meaning assigned to them by the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations or the Narcotic Control Regulations.

• — SOR/2019-134, s. 10

  • 10 The heading before section 30 of the Regulations is repealed.

• — SOR/2019-134, s. 11

  • • 11 (1) The portion of section 30 of the Regulations before paragraph (a) is replaced by the following:

      • Non-application — applicants

        • 30 (1) These Regulations do not apply to

    • (2) Section 30 of the Regulations is amended by adding the following after subsection (1):

      • Non-application — drug for veterinary use only

        (2) These Regulations do not apply to a drug that is for veterinary use only.

• — SOR/2019-134, s. 12

  • 12 The heading before section 31 of the Regulations is repealed.

• — SOR/2019-134, s. 13

  • 13 Subsection 31(2) of the Regulations is replaced by the following:

    • Remission

      (2) Subject to subsection 33(2), if the fee is greater than an amount equal to 1% of the applicant’s actual gross revenue from activities conducted under a dealer’s licence during the previous calendar year, remission is granted of the difference between those amounts if the applicant provides with their application a statement signed by the individual responsible for the applicant’s financial affairs that sets out the actual gross revenue.

• — SOR/2019-134, s. 14

  • 14 Section 32 of the Regulations is repealed.

• — SOR/2019-134, s. 15

  • 15 The headings before section 34 and sections 34 to 53 of the Regulations are repealed.

• — SOR/2019-134, s. 16

  • 16 Schedules 1 to 7 to the Regulations are repealed.

• — SOR/2019-134, s. 20

  • 20 The Fees in Respect of Drugs and Medical Devices Regulations, as they read immediately before the day on which the Regulations Amending and Repealing Certain Regulations Made Under the Financial Administration Act come into force, continue to apply in respect of

    • (a) a fee whose payment is deferred under subsection 9(1), section 10 or subsection 17(4), 35(4), 43(1), 48(3) or 51(4) of the Fees in Respect of Drugs and Medical Devices Regulations to a day that is on or after that day; and

    • (b) a remission referred to in section 11, subsection 17(2), section 44 or subsection 51(2) of the Fees in Respect of Drugs and Medical Devices Regulations.